A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder

By Armstrong Edward P.   Malone Daniel C.   Erder M. Haim  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1115-1121

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial

By Ventura Daniel   Armstrong Edward P.   Skrepnek Grant H.   Haim Erder M.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 245-250

Informa Healthcare

Access to resources Recommend Favorite

Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population

By Wu Eric   Greenberg Paul E.   Yang Elaine   Yu Andrew   Erder M. Haim  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2587-2595

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram in the treatment of major depressive disorder: A meta-analysis

By Kennedy Sidney H.   Andersen Henning F.   Thase Michael E.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 161-175

Informa Healthcare

Access to resources Recommend Favorite

Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants

By Wu Eric   Greenberg Paul   Yang Elaine   Yu Andrew   Ben-Hamadi Rym   Erder M. Haim  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2805-2813

Informa Healthcare

Access to resources Recommend Favorite